Modelling concentration-analgesia relationships for morphine to evaluate experimental pain models.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2015-01-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejps.2014.10.003PMID 25315409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic–Pharmacodynamic Modelling of the Analgesic and Antihyperalgesic Effects of Morphine after Intravenous Infusion in Human Volunteers

  2014cited by this paper
• Human Experimental Pain Models for Assessing the Therapeutic Efficacy of Analgesic Drugs

  2012cited by this paper
• Pain, analgesia and genetics

  2011cited by this paper
• A randomised controlled trial on the efficacy and side‐effect profile (nausea/vomiting/sedation) of morphine‐6‐glucuronide versus morphine for post‐operative pain relief after major abdominal surgery *

  2011cited by this paper
• Epigenetics in pain and analgesia: An imminent research field

  2011cited by this paper
• Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.

  2009cited by this paper
• Pharmacokinetic‐Pharmacodynamic Modeling of Morphine and Oxycodone Concentrations and Analgesic Effect in a Multimodal Experimental Pain Model

  2008cited by this paper
• Morphine in Postoperative Patients: Pharmacokinetics and Pharmacodynamics of Metabolites

  2007cited by this paper
• Pharmacogenetics of Opioids

  2007cited by this paper
• Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies

  2007cited by this paper
• Population pharmacokinetic modelling of subcutaneous morphine in the elderly

  2006cited by this paper
• Multi-modal and tissue-differentiated experimental pain assessment: reproducibility of a new concept for assessment of analgesics.

  2006cited by this paper
• Polymorphism of &mgr;-Opioid Receptor Gene (OPRM1:c.118A>G) Does Not Protect Against Opioid-induced Respiratory Depression despite Reduced Analgesic Response

  2005cited by this paper
• Simultaneous Measurement and Integrated Analysis of Analgesia and Respiration after an Intravenous Morphine Infusion

  2004cited by this paper
• Pharmacokinetic-Pharmacodynamic Modeling of Morphine-6-glucuronide-induced Analgesia in Healthy Volunteers: Absence of Sex Differences

  2004cited by this paper
• Experimental pain in gastroenterology: a reappraisal of human studies

  2003cited by this paper
• Analgesic effects of morphine and morphine‐6‐glucuronide in a transcutaneous electrical pain model in healthy volunteers

  2003cited by this paper
• Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.

  2002cited by this paper
• Pharmacokinetic modeling to predict morphine and morphine‐6‐glucuronide plasma concentrations in healthy young volunteers

  2002cited by this paper
• Limited phase I study of morphine-3-glucuronide.

  2001cited by this paper
• Randomized placebo-controlled trial of the activity of the morphine glucuronides.

  2000cited by this paper
• Sex Differences in Morphine Analgesia: An Experimental Study in Healthy Volunteers

  2000cited by this paper
• Randomized placebo‐controlled trial of the activity of the morphine glucuronides

  2000cited by this paper
• Transgenic analysis of central nervous system development and regeneration

  1997cited by this paper
• Morphine metabolites

  1997cited by this paper
• A Comparison of Intrathecal Morphine-6-Glucuronide and Intrathecal Morphine Sulfate as Analgesics for Total Hip Replacement

  1996cited by this paper
• Morphine‐3‐glucuronide: evidence to support its putative role in the development of tolerance to the antinociceptive effects of morphine in the rat

  1995cited by this paper
• Morphine‐3‐glucuronide may functionally antagonize morphine‐6‐glucuronide induced antinociception and ventilatory depression in the rat

  1992cited by this paper
• Morphine-3-glucuronide--a potent antagonist of morphine analgesia.

  1990cited by this paper
• Patient-controlled Analgesic Therapy, Part IV: Pharmacokinetics and Analgesic Plasma Concentrations of Morphine

  1982cited by this paper
• Patient-controlled Analgesic Therapy, Part III: Pharmacokinetics and Analgesic Plasma Concentrations of Ketobemidone

  1982cited by this paper
• The McGill Pain Questionnaire: Major properties and scoring methods

  1975cited by this paper

• Epidural methadone and morphine pharmacokinetics and clinical effects in healthy volunteers: A randomized, crossover‐design trial

  2024cites this paper
• PBPK-PD model for predicting morphine pharmacokinetics, CNS effects and naloxone antagonism in humans

  2024influential citation
• Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children

  2021cites this paper
• Potentiation of morphine-induced antinociception by harmaline: involvement of μ-opioid and ventral tegmental area NMDA receptors

  2019cites this paper
• Capsaicin‐induced pain and sensitisation in the postpartum period

  2019cites this paper
• DARK Classics in Chemical Neuroscience: Morphine.

  2018cites this paper
• Endogenous Opiates and Behavior: 2016.

  2018cites this paper
• Characterization of cortical source generators based on electroencephalography during tonic pain

  2017cites this paper
• Genetic Influences of OPRM1, OPRD1 and COMT on Morphine Analgesia in a Multi‐Modal, Multi‐Tissue Human Experimental Pain Model

  2017cites this paper
• Cortical and spinal assessment - a comparative study using encephalography and the nociceptive withdrawal reflex.

  2017cites this paper
• Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics

  2017cites this paper
• Morphine Suppresses Lung Cancer Cell Proliferation Through the Interaction with Opioid Growth Factor Receptor: An In Vitro and Human Lung Tissue Study

  2016cites this paper
• Abuse-Deterrent Opioid Formulations: Pharmacokinetic and Pharmacodynamic Considerations

  2016cites this paper
• Zastosowanie chromatografii gazowej do detekcji narkotyków w technice kryminalistycznej

  2016cites this paper
• Pharmacokinetic models of morphine and its metabolites in neonates:: Systematic comparisons of models from the literature, and development of a new meta-model.

  2016cites this paper
• Breakthrough cancer pain: twenty-five years of study

  2016cites this paper
• A review of morphine and morphine-6-glucuronide's pharmacokinetic-pharmacodynamic relationships in experimental and clinical pain.

  2015cites this paper
• The Effect of Oral Morphine on Pain‐Related Brain Activation – An Experimental Functional Magnetic Resonance Imaging Study

  2015cites this paper
• The Brain's Response to Pain and Morphine the Brain's Response to Pain and Morphine – a Study Based on Eeg and Mri the Brain's Response to Pain and Morphine -a Study Based on Eeg and Mri List of Papers

  year unknowncites this paper